-
公开(公告)号:US20170240632A1
公开(公告)日:2017-08-24
申请号:US15519212
申请日:2015-10-16
发明人: David K. THOMAS , Todd GOLUB
CPC分类号: C07K16/2803 , C07K2317/34 , C07K2317/76 , C07K2317/92 , G01N33/6893 , G01N2800/10
摘要: The invention provides therapeutic, engineered protein/peptide compositions comprising e.g., RAGE antibodies, T-cell receptors to target a RAGE receptor (including soluble forms thereof) directly and/or via differential competition with one or more pre-cachexia and/or cachexia-associated RAGE ligands or markers.